Clinical Trial: A prospective, multicenter, real-world study of recombinant human thrombopoietin injection in patients with perioperative thrombocytopenia of chronic liver disease undergoing elective invasive surgery (China)

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter, real-world study of recombinant human thrombopoietin injection in patients with perioperative thrombocytopenia of chronic liver disease undergoing elective invasive surgery'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135798

Registration Time: 2026/11/02

Type: Observational study

Primary Sponsor: Shandong Provincial Qianfoshan Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345632

Published by HT Digital Content Services with permission from Health Daily Digest....